StockData
Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc.

TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3027% above fair value
$682.65−14.35 (-2.06%)

Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%

Thermo Fisher Scientific Life Sciences Solutions Segment by Quarter

Life Sciences Solutions Segment (Total Segment Revenue) ($M)

QuarterlyAnnual

Thermo Fisher Scientific Life Sciences Solutions Segment: $2,719M in Q3 2026, up 5.1% from a year earlier.

Latest, Q3 2026
2,719
Period ended Sep 30, 2026
Change on a year earlier
+5.1%
2,588 in Q3 2025
History
19 quarters
Since Q1 2022
Sources
7
Documents cited below

Where the Q3 2026 figure comes from

“LSS: Revenues 2,341 2,499 2,588 2,946 10,374 2,636 2,815 2,719”

Source: Q3 2026 Reconciliation of Financial Information ↗

Includes 3 operating businesses: Biosciences, Genetic Sciences, and BioProduction.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedLife Sciences Solutions Segment (Total Segment Revenue) ($M)Year on yearSource
Q3 2026Sep 30, 20262,719+5.1%Q3 2026 Reconciliation of Financial Information ↗
Q2 2026Jun 30, 20262,815+12.6%Q3 2026 Reconciliation of Financial Information ↗
Q1 2026Mar 31, 20262,636+12.6%Q3 2026 Reconciliation of Financial Information ↗
Q4 2025Dec 31, 20252,946+13.1%Q3 2026 Reconciliation of Financial Information ↗
Q3 2025Sep 30, 20252,588+8.4%Q3 2026 Reconciliation of Financial Information ↗
Q2 2025Jun 30, 20252,499+6.1%Q3 2026 Reconciliation of Financial Information ↗
Q1 2025Mar 31, 20252,341+2.5%Q3 2026 Reconciliation of Financial Information ↗
Q4 2024Dec 31, 20242,604+5.5%Q4 & FY2025 Reconciliation of Financial Information ↗
Q3 2024Sep 30, 20242,387-1.9%Q4 & FY2025 Reconciliation of Financial Information ↗
Q2 2024Jun 30, 20242,355-4.4%Q4 & FY2025 Reconciliation of Financial Information ↗
Q1 2024Mar 31, 20242,285-12.5%Q4 & FY2025 Reconciliation of Financial Information ↗
Q4 2023Dec 31, 20232,469-18.9%Q4 & FY2024 Reconciliation of Financial Information ↗
Q3 2023Sep 30, 20232,433-17.9%Q4 & FY2024 Reconciliation of Financial Information ↗
Q2 2023Jun 30, 20232,463-25.2%Q4 & FY2024 Reconciliation of Financial Information ↗
Q1 2023Mar 31, 20232,612-38.3%Q4 & FY2024 Reconciliation of Financial Information ↗
Q4 2022Dec 31, 20223,046–SEC Form 8-K (8k_2023Q4, filed 2024-01-31) ↗

Breakdown

What makes up life Sciences Solutions Segment

Cite this data

StockData. (2026). Thermo Fisher Scientific Life Sciences Solutions Segment ($M), quarterly Q1 2022–Q3 2026 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/rev-seg-lss

See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.